Characterization of human pre-elafin mutants: full antipeptidase activity is essential to preserve lung tissue integrity in experimental emphysema
- 13 July 2007
- journal article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 405 (3) , 455-463
- https://doi.org/10.1042/bj20070020
Abstract
Pre-elafin is a tight-binding inhibitor of neutrophil elastase and myeloblastin; two enzymes thought to contribute to tissue damage in lung emphysema. Previous studies have established that pre-elafin is also an effective anti-inflammatory molecule. However, it is not clear whether both functions are linked to the antipeptidase activity of pre-elafin. As a first step toward elucidating the structure/function relationship of this protein, we describe here the construction and characterization of pre-elafin variants with attenuated antipeptidase potential. In these mutants, the P1' methionine residue of the inhibitory loop is replaced by either a lysine (pre-elafinM25K) or a glycine (pre-elafinM25G) residue. Both mutated variants are stable and display biochemical properties undistinguishable from WT (wild-type) pre-elafin. However, compared with WT pre-elafin, their inhibitory constants are increased by one to four orders of magnitude toward neutrophil elastase, myeloblastin and pancreatic elastase, depending on the variants and enzymes tested. As suggested by molecular modelling, this attenuated inhibitory potential correlates with decreased van der Waals interactions between the variants and the enzymes S1' subsite. In elastase-induced experimental emphysema in mice, only WT pre-elafin protected against tissue destruction, as assessed by the relative airspace enlargement measured using lung histopathological sections. Pre-elafin and both mutants prevented transient neutrophil alveolitis. However, even the modestly affected pre-elafinM25K mutant, as assayed in vitro with small synthetic substrates, was a poor inhibitor of the neutrophil elastase and myeloblastin elastolytic activity measured with insoluble elastin. We therefore conclude that full antipeptidase activity of pre-elafin is essential to protect against lung tissue lesions in this experimental model.Keywords
This publication has 43 references indexed in Scilit:
- Oxidized elafin and trappin poorly inhibit the elastolytic activity of neutrophil elastase and proteinase 3The FEBS Journal, 2005
- Differences between human proteinase 3 and neutrophil elastase and their murine homologues are relevant for murine model experimentsFEBS Letters, 2005
- Pathogenesis of COPDSeminars in Respiratory and Critical Care Medicine, 2005
- Kinetics of the inhibition of neutrophil proteinases by recombinant elafin and pre‐elafin (trappin‐2) expressed in Pichia pastorisEuropean Journal of Biochemistry, 2004
- Supernatants of Pseudomonas aeruginosa induce the Pseudomonas‐specific antibiotic elafin in human keratinocytesExperimental Dermatology, 2003
- The Crystal Structure of PR3, a Neutrophil Serine Proteinase Antigen of Wegener's Granulomatosis AntibodiesJournal of Molecular Biology, 1996
- Demonstration of Skin-Derived Antileukoproteinase (SKALP) in Urine of Psoriatic PatientsJournal of Investigative Dermatology, 1992
- Synthesis and structure-activity relationships of elafin, an elastase-specific inhibitorBiochemical and Biophysical Research Communications, 1992
- The Behavior and Significance of Slow‐Binding Enzyme InhibitorsPublished by Wiley ,1988